Insights on Cannabis and Tobacco Use Impact on Brain Volumes
The cannabis tobacco brain volume study highlights associations between use and reduced brain volumes in specific regions. These findings raise important questions about long-term safety, especially for younger patients. Clinical interpretation requires…
Alcohol, Tobacco, and Opioid Addictions Share Genetic Roots
Understanding shared genetic vulnerability substance use disorders helps clinicians identify patients at risk for multiple addictions. This knowledge supports integrated screening and treatment approaches. Recognizing genetic overlap can improve…
New Research Reveals Age Plays Key Role in Cannabis‑Related Psychiatric Risks
New research highlights cannabis-related psychiatric risks adolescents face compared to adults. This study emphasizes the importance of age in evaluating cannabis's mental health impact. Clinicians should tailor screening and interventions accordingly.
Cannabis Compound Shows Promise in Fighting Alzheimer’s by Calming Brain Inflammation
Cannabis compounds alzheimers research highlights potential to calm brain inflammation, a key factor in neurodegeneration. Emerging evidence suggests cannabinoids may modulate neuroinflammatory pathways involved in Alzheimer's disease. Clinicians should…
Genes Influencing Impulse Control and Addiction Risk
Genetic predisposition addiction risk plays a crucial role in poor impulse control linked to cannabis use disorder. Understanding these genetic factors helps clinicians identify patients at higher addiction risk. This knowledge supports personalized…
Radical Revelations: Nitrosative Stress and the Endocannabinoid System
Understanding nitrosative stress endocannabinoid system interactions is crucial for predicting patient responses to cannabis-based therapies. This knowledge aids clinicians in personalizing treatments for neuroinflammatory and oxidative stress disorders.…
Specific Forms of Substance Misuse Increase Stroke Risk – MPR – eMPR.com
Emerging evidence links cannabis use disorder stroke risk to increased incidence of stroke, especially in younger patients. Clinicians should screen for cannabis use disorder stroke risk when assessing stroke causes. Understanding cannabis use disorder…
The Science Behind Cannabis and Neuroprotective Benefits – NUG Magazine
Emerging scientific evidence highlights cannabis neuroprotective benefits relevant to neurological conditions. Cannabinoids show promise in neuroprotection, though clinical data remain limited. Ongoing research and CME programs aim to clarify cannabis's…
Rethinking Cannabis and Its Effects on the Aging Brain
Understanding aging brain cannabis effects is crucial for clinicians treating older adults. Cannabis use among seniors is rising despite limited safety data. This article reviews key considerations for cognitive function and neurodegeneration in…
Ethics Committee in the Netherlands Approves Parkinson’s Cannabis Trial
The cannabis-derived therapeutic candidate Parkinson's disease trial has received ethics committee approval in the Netherlands. This milestone advances clinical evidence for cannabinoid treatments in neurodegenerative conditions. Clinicians should…